Nyxoah S A (NYXH) Stock Price, Quote & News

Company Profile

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 32 1 022 23 55

Fax: 32 1 045 90 75

Website: www.nyxoah.com

Address:

Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium

ZacksResearch Dec. 1 at 2:33 PM

$NYXH down 40% so far this year but could a CMS reimbursement boost improve prospects in 2026? 🔄 🩺 CPT Code 64568 rates up 48% for hospitals and 58% for ASCs in 2026 💸 New rates could drive adoption and expand Medicare-heavy institutions See how this could impact NYXH's future here 👉 https://www.zacks.com/stock/news/2797639/nyxoah-gains-favorable-cms-reimbursement-ruling-for-genio-system?cid=sm-stocktwits-2-2797639-body-22848&ADID=SYND_STOCKTWITS_TWEET_2_2797639_BODY_22848

0 · Reply

ZacksResearch Dec. 1 at 1:33 PM

Big win for $NYXH — this CMS ruling could be a real momentum catalyst. The finalized 2026 reimbursement for its Genio implants jumps sharply, giving its OSA therapy a much stronger commercial runway. See what this means for the setup 👉 https://www.zacks.com/stock/news/2797639/nyxoah-gains-favorable-cms-reimbursement-ruling-for-genio-system?cid=sm-stocktwits-2-2797639-teaser-22846&ADID=SYND_STOCKTWITS_TWEET_2_2797639_TEASER_22846

0 · Reply

mikesterz7 Nov. 26 at 1:38 PM

$NYXH Nyxoah expects the stronger reimbursement framework to support broader adoption, increase procedural throughput, and expand across Medicare-heavy institutions.

0 · Reply

StocktwitsNews Nov. 26 at 1:29 PM

Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy $NYXH $BMED $INSP https://stocktwits.com/news/equity/markets/nyxoah-sa-stock-rises-pre-market-after-cms-raises-reimbursement-for-sleep-disorder-therapy/cL538b3REWB

0 · Reply

mebanks Nov. 26 at 11:47 AM

$NYXH , some good news here as well "Effective January 1, 2026, Hospital Outpatient Department (HOPD) reimbursement for CPT 64568 will increase to approximately $45,000, a 48% rise compared to 2025. In addition, Ambulatory Surgery Centers (ASC) facility reimbursement will increase to $42,373, reflecting a 58% increase compared to 2025." Be careful as this prospectus for 1.2M shares was updated 9 days ago https://www.sec.gov/Archives/edgar/data/1857190/000110465925112911/tm2531378-1_424b5.htm

0 · Reply

xyzxyzxyz1978 Nov. 25 at 6:22 AM

$NYXH uses the same CPT code as $INSP.

0 · Reply

Al818181 Nov. 18 at 11:19 PM

$NYXH Long here. Genio entering the UC system in California. Expecting this to replace Inspire.

0 · Reply

Noobnr1 Nov. 18 at 3:55 PM

$NYXH 🚀💎🚀 C’mon

0 · Reply

JarvisFlow Nov. 14 at 4:15 PM

Piper Sandler has updated their rating for Nyxoah ( $NYXH ) to Overweight with a price target of 9.

0 · Reply

Pacho_Unlimited1 Nov. 13 at 9:28 PM

$NYXH GREAT NUMBERS!

0 · Reply

Publication relating to transparency notifications

Nov 27, 2025, 4:05 PM EST - 7 days ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 26, 2025, 1:45 AM EST - 8 days ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Nov 20, 2025, 4:30 PM EST - 14 days ago

Information on the total number of voting rights and shares

Nov 13, 2025, 9:01 PM EST - 21 days ago

Nyxoah SA (NYXH) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 4:36 PM EST - 21 days ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:12 PM EST - 21 days ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 3, 2025, 4:05 PM EST - 4 weeks ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Oct 30, 2025, 5:10 PM EDT - 5 weeks ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 6, 2025, 1:00 AM EDT - 2 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Sep 23, 2025, 4:10 PM EDT - 2 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 15, 2025, 4:10 PM EDT - 2 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 10, 2025, 2:50 AM EDT - 3 months ago

Nyxoah SA (NYXH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 4:30 PM EDT - 3 months ago

Nyxoah Announces Upcoming Investor Events

Aug 20, 2025, 8:00 AM EDT - 3 months ago

Nyxoah: High-Risk High-Reward Medtech To Own

Aug 18, 2025, 7:07 PM EDT - 3 months ago

Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript

Aug 18, 2025, 4:10 PM EDT - 3 months ago

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 11, 2025, 1:00 AM EDT - 4 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 8, 2025, 4:10 PM EDT - 4 months ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Jul 29, 2025, 4:30 PM EDT - 4 months ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 28, 2025, 4:05 PM EDT - 4 months ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jun 13, 2025, 1:00 AM EDT - 6 months ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

May 28, 2025, 4:30 PM EDT - 6 months ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 14, 2025, 2:35 PM EDT - 7 months ago

Nyxoah SA (NYXH) Q1 2025 Earnings Call Transcript

May 14, 2025, 1:00 AM EDT - 7 months ago

Nyxoah Reports First Quarter Financial and Operating Results

May 9, 2025, 1:00 AM EDT - 7 months ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

Apr 22, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Apr 21, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Apr 20, 2025, 10:00 AM EDT - 8 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 18, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Apr 17, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Apr 16, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Apr 16, 2025, 2:00 AM EDT - 8 months ago

Conditional Issuance of Shares

Apr 15, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Apr 14, 2025, 10:00 AM EDT - 8 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 11, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Apr 10, 2025, 10:00 AM EDT - 8 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 9, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Apr 8, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Apr 8, 2025, 1:00 AM EDT - 8 months ago

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Apr 7, 2025, 3:00 PM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

Apr 7, 2025, 9:33 AM EDT - 8 months ago

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Mar 31, 2025, 5:40 PM EDT - 8 months ago

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Mar 31, 2025, 2:45 PM EDT - 8 months ago

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.

Mar 26, 2025, 3:00 AM EDT - 9 months ago

FDA Issues Nyxoah an Approvable Letter for its Genio® System

ZacksResearch Dec. 1 at 2:33 PM

0 · Reply

ZacksResearch Dec. 1 at 1:33 PM

0 · Reply

mikesterz7 Nov. 26 at 1:38 PM

$NYXH Nyxoah expects the stronger reimbursement framework to support broader adoption, increase procedural throughput, and expand across Medicare-heavy institutions.

0 · Reply

StocktwitsNews Nov. 26 at 1:29 PM

0 · Reply

mebanks Nov. 26 at 11:47 AM

0 · Reply

xyzxyzxyz1978 Nov. 25 at 6:22 AM

$NYXH uses the same CPT code as $INSP.

0 · Reply

Al818181 Nov. 18 at 11:19 PM

$NYXH Long here. Genio entering the UC system in California. Expecting this to replace Inspire.

0 · Reply

Noobnr1 Nov. 18 at 3:55 PM

$NYXH 🚀💎🚀 C’mon

0 · Reply

JarvisFlow Nov. 14 at 4:15 PM

Piper Sandler has updated their rating for Nyxoah ( $NYXH ) to Overweight with a price target of 9.

0 · Reply

Pacho_Unlimited1 Nov. 13 at 9:28 PM

$NYXH GREAT NUMBERS!

0 · Reply

Noobnr1 Nov. 13 at 4:15 PM

$BEAM C’mon let’s go again thanks $PFE $NYXH numbers after hours 🚀🚀🚀 $PHAR 🥇🐇

0 · Reply

TheVirus0011 Nov. 13 at 12:54 PM

$NYXH results today

0 · Reply

Noobnr1 Nov. 10 at 5:28 PM

$NYXH 🚀💎 $PHAR 🐇🚀 $DVAX 🚀🤞 C’mon big ones $GILD and $PFE 🙏🙏

0 · Reply

TheVirus0011 Oct. 27 at 3:34 PM

$TNXP it's time to fly $LASE $PSTV $TLRY $NYXH

0 · Reply

Culby Oct. 24 at 6:37 PM

$NYXH anyone alive on this board??

0 · Reply

Culby Oct. 15 at 3:50 PM

$NYXH why is this dropping back down?

0 · Reply

TheVirus0011 Oct. 13 at 6:27 PM

$PSTV Good evening, some people are talking about November 13-14-15 for the results, on Trading View they say in 3 days, when will the results actually come out? $HUMA $LASE $NYXH

2 · Reply

TheVirus0011 Oct. 10 at 6:44 PM

$PSTV Hello, I'm from Belgium. I can't figure out why the market is bright red and the VIX is soaring. Can someone tell me in the comments, please? $NYXH $LASE $HUMA

3 · Reply

Hernandrod12 Oct. 7 at 8:52 PM

$NYXH $BURU $SPRB I told everyone this would happen everyone who followed me here it’s time for BURU this one is also going to explode! Do your own DD and youll see! Military tekne partnership Bullish

0 · Reply

ZacksResearch Oct. 7 at 4:48 PM

$NYXH soars 17.2% on U.S. debut of Genio system! 🚀 The first U.S. commercial implants are in, backed by strong physician demand, expanding payor coverage, and streamlined hospital approvals. This marks a pivotal step towards a potential revenue ramp for Nyxoah in the sleep apnea market. Discover the full story here 👉 https://www.zacks.com/stock/news/2763871/nyxoah-shares-rise-on-first-us-commercial-use-of-genio-system?cid=sm-stocktwits-2-2763871-body-14972&ADID=SYND_STOCKTWITS_TWEET_2_2763871_BODY_14972

0 · Reply

ZacksResearch Oct. 7 at 3:48 PM

$NYXH pops after first U.S. commercial use of its Genio system — major milestone for the company. The debut shows strong physician demand and paves the way for broader adoption in sleep apnea treatment, a big step for growth potential. See what this means for NYXH’s next phase of expansion 👉 https://www.zacks.com/stock/news/2763871/nyxoah-shares-rise-on-first-us-commercial-use-of-genio-system?cid=sm-stocktwits-2-2763871-teaser-14962&ADID=SYND_STOCKTWITS_TWEET_2_2763871_TEASER_14962

0 · Reply

topstockalerts Oct. 7 at 1:20 PM

$NYXH there it goes!! 👀

0 · Reply

Market Cap	160.42M
Revenue (ttm)	4.89M
Net Income (ttm)	-64.10M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,310.84%
Debt to Equity Ratio	0.37

Volume	25,000
Avg Vol	60,768
Day's Range	N/A - N/A
Shares Out	34.06M
Stochastic %K	65%
Beta	1.55
Analysts	Strong Sell
Price Target	$11.25